Examkin

Soru

Zorluk: ZorBreast and Endocrine Surgery

A 49-year-old postmenopausal woman presents to the surgical breast clinic due to a 5-week history of right breast swelling, redness, and a feeling of heaviness. She was initially evaluated by her primary care provider and completed a 10-day course of oral cephalexin for presumed mastitis, but her symptoms have progressively worsened. She has no personal or family history of breast cancer. Her temperature is 37.1°C (98.8°F). Physical examination reveals a diffusely enlarged right breast with prominent erythema covering approximately 60% of the breast surface. The skin demonstrates a pitted, edematous appearance resembling an orange peel (peau d'orange). A poorly defined, firm area is palpated deep within the central quadrant. A 1.5-cm firm, mobile lymph node is palpable in the right axilla. Arrange the following steps in the most appropriate chronological sequence for the optimal evaluation and definitive management of this patient.

  1. 1Bilateral diagnostic mammography and targeted right breast ultrasound
  2. 2Core needle biopsy of the underlying breast tissue and punch biopsy of the affected skin
  3. 3Administration of neoadjuvant systemic chemotherapy
  4. 4Surgical resection via a modified radical mastectomy
  5. 5Administration of comprehensive post-mastectomy radiation therapy

Cevap

The correct sequence for managing suspected inflammatory breast cancer is initial imaging (mammography/ultrasound), followed by tissue diagnosis (core needle and skin punch biopsies), induction with neoadjuvant systemic chemotherapy, definitive surgical resection via modified radical mastectomy, and finally post-mastectomy radiation therapy.
Inflammatory breast cancer (IBC) presents with rapid-onset erythema, edema (peau d'orange), and a palpable mass, mimicking mastitis but failing to respond to antibiotics. The definitive management sequence follows a strict multidisciplinary protocol. Initial non-invasive evaluation requires bilateral mammography and targeted ultrasound to assess disease extent. This is immediately followed by tissue acquisition via core needle biopsy of the mass and a skin punch biopsy to confirm dermal lymphatic emboli (the hallmark of IBC). Because IBC is exceptionally aggressive and considered locally advanced at presentation, neoadjuvant systemic chemotherapy is the mandatory next step to achieve cytoreduction and eradicate early micrometastases. Once chemotherapy is completed, surgical consolidation is performed. Due to the diffuse nature of the disease, breast-conserving surgery is contraindicated; a modified radical mastectomy must be performed. The protocol concludes with comprehensive post-mastectomy radiation therapy to the chest wall and regional lymph nodes to minimize the high risk of locoregional recurrence.

Adım Adım Çözüm

1
Obtain diagnostic imaging (mammography and ultrasound).
Characterizes the primary breast mass, evaluates regional lymph nodes, and screens the contralateral breast.
Imaging must precede biopsy to prevent biopsy-induced hematomas or architectural distortion from obscuring radiological interpretation.
2
Perform core needle and skin punch biopsies.
Provides histologic confirmation of invasive carcinoma and dermal lymphatic invasion.
Definitive tissue diagnosis and receptor status profiling (ER, PR, HER2) are absolutely required before initiating any oncologic therapy.
3
Initiate neoadjuvant systemic chemotherapy.
Addresses micrometastatic disease and frequently downstages the primary tumor.
Inflammatory breast cancer is highly aggressive and considered unresectable upfront. Systemic therapy is the standard first-line treatment to improve overall survival and make the disease surgically operable.
4
Perform a modified radical mastectomy.
Removes the entire breast parenchyma, overlying affected skin, and level I/II axillary lymph nodes.
Surgical consolidation is required after chemotherapy. Breast-conserving surgery is universally contraindicated in inflammatory breast cancer due to unacceptably high local recurrence rates.
5
Administer post-mastectomy radiation therapy.
Eradicates microscopic residual disease in the chest wall and regional lymphatics.
Maximizes locoregional control, which is critical given the diffuse, rapidly spreading nature of inflammatory breast cancer.

Anahtar Kavram

The standard multidisciplinary management sequence for inflammatory breast cancer.

Alternatif Yöntem

While the core sequence (Chemo -> Surgery -> Radiation) remains strict, targeted biological therapies (e.g., Trastuzumab, Pertuzumab) are incorporated into the neoadjuvant chemotherapy phase if the core needle biopsy reveals HER2-positive status.
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Breast and Endocrine Surgery

Bu konudan daha fazla soru